BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32326889)

  • 1. Reduced risk of post ERCP pancreatitis in statin users.
    Hadi YB; Naqvi SF; Abdelqader A; Kupec J; Nasr J
    BMC Gastroenterol; 2020 Apr; 20(1):125. PubMed ID: 32326889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin consumption and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Martínez-Moneo E; Cárdenas-Jaén K; Fernández-Laso AB; Millastre-Bocos J; Torralba-Gallego A; Martín-Arriero S; Alfaro-Almajano E; García-Rayado G; de-Madaria E
    Pancreatology; 2020 Jul; 20(5):801-805. PubMed ID: 32448748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study.
    Cárdenas-Jaén K; Archibugi L; Poropat G; Korpela T; Maisonneuve P; Aparicio JR; Udd M; Stimac D; Arcidiacono PG; De Pretis N; Valente R; Di Giulio E; Casellas JA; Kylänpää L; Hauser G; Mariani A; Gabbrielli A; Löhr M; Vanella G; Rainio M; Brozzi L; Arnelo U; Fagerström N; Capurso G; de-Madaria E
    Dig Endosc; 2021 May; 33(4):639-647. PubMed ID: 32713065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic use of statins and risk of post-ERCP acute pancreatitis (STARK): Study protocol for an international multicenter prospective cohort study.
    Korpela T; Cárdenas-Jaén K; Archibugi L; Poropat G; Maisonneuve P; Arcidiacono PG; De Pretis N; Löhr M; Capurso G; de-Madaria E
    Dig Liver Dis; 2018 Dec; 50(12):1362-1365. PubMed ID: 30224317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular Statin Use and Incidence of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Hakuta R; Nakai Y; Hamada T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Nakamura T; Sato T; Ishigaki K; Saito K; Saito T; Takahara N; Mizuno S; Kogure H; Tada M; Koike K
    J Clin Gastroenterol; 2020; 54(10):905-910. PubMed ID: 31895166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
    Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
    Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
    Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
    Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
    J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
    Lin Y; Liu X; Cao DQ; Tang JH; Wen JJ; Li TF; Liu PF; Xia TS
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5185-5190. PubMed ID: 29228432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
    Thiruvengadam NR; Forde KA; Chandrasekhara V; Ahmad NA; Ginsberg GG; Khungar V; Kochman ML
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1224-1232.e1. PubMed ID: 31622734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Park CH; Park SW; Yang MJ; Moon SH; Park DH
    Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography in patients with biliary tract diseases.
    Chi JY; Ma LY; Zou JC; Ma YF
    BMC Surg; 2023 Mar; 23(1):62. PubMed ID: 36959589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.